RECRUITINGOBSERVATIONAL
Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome
About This Trial
This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome. Patients who have already received 2 weeks of peloid therapy or 15 sessions of paraffin treatment will be assessed. Pain and symptom severity are assessed using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological examinations will also be conducted at the same time points: baseline, 4 weeks post-treatment, and a 12-week follow-up.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients aged between 18 and 65 years old.
- Patients diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological evaluations.
- Patients experiencing symptoms for a minimum of 3 months.
Who Should NOT Join This Trial:
- Patients diagnosed with neuropathic conditions such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome.
- Patients with a history of previous injections or surgery for carpal tunnel syndrome.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients aged between 18 and 65 years old.
* Patients diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological evaluations.
* Patients experiencing symptoms for a minimum of 3 months.
Exclusion Criteria:
* Patients diagnosed with neuropathic conditions such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome.
* Patients with a history of previous injections or surgery for carpal tunnel syndrome.
Treatments Being Tested
OTHER
No intervention
No intervention.
Locations (1)
Beylikdüzü State Hospital
Istanbul, Turkey (Türkiye)